The board of directors of Viva Biotech Holdings announces that Mr. HUA Fengmao ("Mr. HUA") has tendered his resignation from the office of executive Director of the Company on June 30, 2021 with immediate effect, he has also tendered his resignation as chairman of the board and director for Zhejiang Langhua Pharmaceutical Co. Ltd. The Company will arrange to nominate a director and chairman to the board of Langhua Pharmaceutical following Mr. HUA's resignation. Mr. HUA resigned from his positions in order to devote more time to pursue his other business engagements and has confirmed that he has no claim against the Company in respect of his resignation and has no disagreement with the Board. Mr. HUA has further confirmed that there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company in connection with his resignation and The Stock Exchange of Hong Kong Limited. Mr. HUA will cease to be an authorized representative ("Authorized Representative(s)") under Rule 3.05 of the Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited following his resignation as an executive Director. The Company has appointed Mr. WU Ying ("Mr. WU"), an executive Director as an Authorized Representative and subsequent to such appointment, Mr. WU and Ms. CHAU Hing Ling shall be the Authorized Representatives of the Company.